YSB (HKSE:09885) GF Value : HK$0.00 (As of Mar. 26, 2025)

View and export this data going back to 2023. Start your Free Trial

What is YSB GF Value?

As of today (2025-03-26), YSB's share price is HK$6.68. YSB's GF Value is HK$0.00. Therefore, YSB's Price-to-GF-Value for today is . Based on the relationship between the current stock price and the GF Value, GuruFocus believes YSB is Not Valued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

YSB (HKSE:09885) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

YSB's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	6.68	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YSB GF Value Related Terms

Thank you for viewing the detailed overview of YSB's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

B1S:Germany

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
H Capital V, L.p.	2101 Beneficial owner
Tmf (cayman) Ltd.	2301 Trustee
Tiger Global Private Investment Partners Xi, L.p.	2101 Beneficial owner
Tiger Global Pip Performance Xi, L.p.	2201 Interest of corporation controlled by you
Tiger Global Management, Llc	2102 Investment manager
Shleifer Scott	2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd.	2201 Interest of corporation controlled by you
Coleman Iii Charles	2201 Interest of corporation controlled by you
Miyt Worldwide Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner
Internet Fund V Pte. Ltd.	2306 Nominee for another person
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner

YSB Headlines

No Headlines